These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 1666447)

  • 1. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
    Shepp DH; Dandliker PS; Meyers JD
    Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella and herpes zoster infections in immunocompromised host: prevention and treatment.
    Ramírez Palacios RM; Sánchez J; Bermúdez RH; Ramírez Ronda CH
    Bol Asoc Med P R; 1986 Apr; 78(4):142-5. PubMed ID: 2424477
    [No Abstract]   [Full Text] [Related]  

  • 9. Varicella-zoster virus: prospects for control.
    Gershon AA
    Adv Pediatr Infect Dis; 1995; 10():93-124. PubMed ID: 7718215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella zoster virus: review of its management.
    Mustafa MB; Arduino PG; Porter SR
    J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
    Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
    Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses].
    Vogt M; Huss R; Wunderli W
    Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to varicella-zoster virus infections.
    Whitley RJ
    J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy for varicella and herpes zoster.
    Arvin AM
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.